|
|
Urinary Sodium Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort Population
|
|
|
|
|
نویسنده
|
saulnier p.-j. ,gand e. ,ragot s. ,bankir l. ,piguel x. ,fumeron f. ,rigalleau v. ,halimi j.-m. ,marechaud r. ,roussel r. ,hadjadj s. ,ducrocq g. ,llatty p. ,hulin-delmotte c. ,montaigne d. ,zaoui p. ,javaugue v. ,pucheu y. ,gatault p. ,sosner p. ,gellen b.
|
منبع
|
journal of diabetes research - 2017 - دوره : 2017 - شماره : 0
|
چکیده
|
Objective. sodium intake is associated with cardiovascular outcomes. however,no study has specifically reported an association between cardiovascular mortality and urinary sodium concentration (una). we examined the association of una with mortality in a cohort of type 2 diabetes (t2d) patients. methods. patients were followed for all-cause death and cardiovascular death. baseline una was measured from second morning spot urinary sample. we used cox proportional hazard models to identify independent predictors of mortality. improvement in prediction of mortality by the addition of una to a model including known risk factors was assessed by the relative integrated discrimination improvement (ridi) index. results. participants (n=1,439) were followed for a median of 5.7 years,during which 254 cardiovascular deaths and 429 all-cause deaths were recorded. una independently predicted all-cause and cardiovascular mortality. an increase of one standard deviation of una was associated with a decrease of 21% of all-cause mortality and 22% of cardiovascular mortality. una improved all-cause and cardiovascular mortality prediction beyond identified risk factors (ridi = 2.8%,p=0.04 and ridi = 4.6%,p=0.02,resp.). conclusions. in t2d,una was an independent predictor of mortality (low concentration is associated with increased risk) and improved modestly its prediction in addition to traditional risk factors. © 2017 pierre-jean saulnier et al.
|
|
|
آدرس
|
chu de poitiers,centre d'investigation clinique,poitiers,france,université de poitiers,ufr médecine pharmacie,cic1402,poitiers,france,inserm,cic1402,poitiers, France, chu poitiers,pole dune,poitiers, France, chu de poitiers,centre d'investigation clinique,poitiers,france,université de poitiers,ufr médecine pharmacie,cic1402,poitiers,france,inserm,cic1402,poitiers, France, inserm,umrs1138,centre de recherche des cordeliers,paris,france,université paris 6 pierre et marie curie,centre de recherche des cordeliers,paris, France, chu poitiers,pole dune,poitiers, France, inserm,umrs1138,centre de recherche des cordeliers,paris,france,université paris 6 pierre et marie curie,centre de recherche des cordeliers,paris,france,université paris 7 denis diderot,umrs1138,centre de recherche des cordeliers,paris, France, chu bordeaux,service d'endocrinologie,diabétologie,maladies métaboliques et nutrition,bordeaux, France, chu tours,service de néphrologie,tours,france,université de tours,faculté de médecine,tours, France, chu poitiers,pole dune,poitiers, France, inserm,umrs1138,centre de recherche des cordeliers,paris,france,université paris 6 pierre et marie curie,centre de recherche des cordeliers,paris,france,université paris 7 denis diderot,umrs1138,centre de recherche des cordeliers,paris,france,chu bordeaux,service d'endocrinologie,diabétologie,maladies métaboliques et nutrition,bordeaux, France, chu de poitiers,centre d'investigation clinique,poitiers,france,université de poitiers,ufr médecine pharmacie,cic1402,poitiers,france,inserm,cic1402,poitiers,france,chu poitiers,pole dune,poitiers,france,inserm,u1082,poitiers, France, paris,france,assistance public-hôpitaux de paris, France, assistance public-hôpitaux de paris, France, assistance public-hôpitaux de paris, France, chu lille, France, chu grenoble, France, chu poitiers, France, chu bordeaux,service d'endocrinologie,diabétologie,maladies métaboliques et nutrition,bordeaux, France, chu tours,service de néphrologie,tours, France, laboratoire move ea6314, France, polyclinique de poitiers, France
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|